Neo Q strengthens its management and continues to focus on growth

The experienced healthcare expert Dr Sven Jansen forms a new strong management duo with founder and ceo Professor Dr Alexander Huppertz.

Dr Sven Jansen, 48, has been appointed to the management board of Neo Q Quality in Imaging GmbH as of April 2023. Together with managing director Professor Dr Alexander Huppertz, he will strengthen and further promote the successful development of the Berlin-based health IT company. The company, which specialises in AI-supported radiological reporting, is thus taking the next step towards strategic and international growth.

Professor Huppertz: “With Dr Jansen, we have been able to gain a competent leader and an excellent expert in the health sector. Together with our shareholders, I am very much looking forward to the cooperation. Based on our strategic orientation, we will set the course for a successful future of Neo Q with its innovative technology of Guided Reporting and its product RadioReport.”

After his international studies, Dr Jansen started his career as a biochemist with a doctorate in 2001 at the Cooperation Centre for Medicine at the University of Bremen. From 2005 onwards, he worked in various management consultancies in the healthcare industry and life sciences, including a senior position in the strategy and management consultancy of Booz Allen Hamilton, later booz&co. with duty stations in Dubai and Abu Dhabi. In 2009, he moved to GE Healthcare, where he held various global leadership positions in Munich, Paris and Chicago within the worldwide group, before joining CSC Healthcare, now DXC Technology, in 2012 as industry general manager and managing partner at the Hamburg location. From 2017 to 2022, he was first managing director and then member of the executive board of the Munich-based NOVENTI group of companies. From mid-2022, he moved to the management of INNO3 GmbH in Leipzig.

Dr Sven Jansen is looking forward to his new task: “My core vision is the sustainable digital transformation of the healthcare system. With our Guided Reporting technology, we have the chance to massively drive long overdue developments.”

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more